A Study of LP-118 in Patients With Advanced Tumors

Clinical trial NCT05025358 · COMPLETED

Trial details

NCT number: NCT05025358
Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Lymphoma, Non-Hodgkin

Start date: 2021-09-08
Primary completion: 2025-07-09
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.